Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice
- PMID: 10864685
- PMCID: PMC112181
- DOI: 10.1128/jvi.74.14.6680-6683.2000
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice
Abstract
Murine models of gamma interferon (IFN-gamma) deficiency demonstrate the role of this cytokine in attenuating acute herpes simplex virus (HSV) disease; however, the effect of IFN-gamma on the establishment and maintenance of neuronal latency and viral reactivation is not known. Using the IFN-gamma knockout (GKO) model of IFN-gamma deficiency and sensitive quantitative PCR methods, we show that IFN-gamma significantly reduces the ganglion content of latent HSV-1 in BALB/c mice, which in turn delays viral time to reactivation following UV irradiation. Similar effects were not seen in the C57BL/6 strain. These results indicate that IFN-gamma significantly attenuates latent HSV infection in the mouse model of ocular infection but has no impact on the maintenance of latency or virus reactivation.
Figures





References
-
- Araneo B A, Dowel T, Moon H B, Daynes R A. Regulation of murine lymphokine production in vivo. Ultraviolet radiation exposure depresses IL-2 and enhances IL-4 production by T cells through an IL-1 dependent mechanism. J Immunol. 1989;143:1737–1744. - PubMed
-
- Bouley D M, Kanangat S, Wire W, Rouse B T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J Immunol. 1995;155:3964–3971. - PubMed
-
- Burchett S K, Corey L, Mohan K M, Westall J, Ashley R, Wilson C B. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis. 1992;165:813–818. - PubMed
-
- Bustamante C I, Wade J C. Herpes simplex virus infection in the immunocompromised cancer patient. J Clin Oncol. 1991;10:1903–1915. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources